Výsledky vyhledávání

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

Autor: Biemans, Vince B. C., Sleutjes, Jasmijn A. M., de Vries, Annemarie C., Bodelier, Alexander G. L., Dijkstra, Gerard, Oldenburg, Bas, Löwenberg, Mark, van Bodegraven, Adriaan A., van der Meulen-de Jong, Andrea E., de Boer, Nanne K. H., Srivastava, Nidhi, West, Rachel L., Römkens, Tessa E. H., Horjus Talabur Horje, Carmen S., Jansen, Jeroen M., van der Woude, C. Janneke, Hoekstra, Jildou, Weersma, Rinse K., van Schaik, Fiona D. M., Hoentjen, Frank, Pierik, Marieke J., Fidder, H. H., Ponsioen, C. Y., Duijvestein, M., Romberg-Camps, M. J. L., Maljaars, P. W. J., Bouma, G., van der Marel, S., de Jong, D. J., Haans, J. J. L.

Publikováno v: Alimentary Pharmacology & Therapeutics, 51(9), 880-888. Wiley
Alimentary Pharmacology & Therapeutics, 51, 9, pp. 880-888
Alimentary Pharmacology and Therapeutics, 51(9), 880-888
Alimentary Pharmacology and Therapeutics, 51(9), 880-888. Wiley-Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics
Alimentary pharmacology & therapeutics, 51(9), 880-888. Wiley-Blackwell
Biemans, V B C, Sleutjes, J A M, de Vries, A C, Bodelier, A G L, Dijkstra, G, Oldenburg, B, Löwenberg, M, van Bodegraven, A A, van der Meulen-de Jong, A E, de Boer, N K H, Srivastava, N, West, R L, Römkens, T E H, Horjus Talabur Horje, C S, Jansen, J M, van der Woude, C J, Hoekstra, J, Weersma, R K, van Schaik, F D M, Hoentjen, F, Pierik, M J & the Dutch Initiative on Crohn and Colitis (ICC) 2020, ' Tofacitinib for ulcerative colitis : results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ', Alimentary Pharmacology and Therapeutics, vol. 51, no. 9, pp. 880-888 . https://doi.org/10.1111/apt.15689
Alimentary Pharmacology & Therapeutics, 51, 880-888
Alimentary Pharmacology and Therapeutics, 51(9), 880-888. WILEY

Contains fulltext : 220023.pdf (Publisher’s version ) (Open Access) BACKGROUND: Tofacitinib is a Janus kinase inhibitor approved for the treatment of ulcerative colitis (UC). AIM: To evaluate effectiveness, safety and use of tofacitinib in daily pr

Vyhledávací nástroje:

Upřesnit hledání